Parkinson's disease (PD) is a complex neurodegenerative disorder driven by a combination of genetic and environmental factors. While most cases cannot be attrib...
Continue reading
Clinical trial populations consistently fail to reflect the demographics of the populations most affected by the diseases being studied. This gap is not simply ...
Continue reading
In precision medicine trials, DNA sequencing is not a background step. It determines eligibility, shapes enrollment pathways, and directly influences the qualit...
Continue reading
In genetically stratified trials, patient recruitment is structurally harder than in conventional studies. Eligibility depends not just on clinical diagnosis, b...
Continue reading
Running clinical trials across the European Union (EU) and the United States (US) means operating within two fundamentally different systems. Regulatory framewo...
Continue reading
Patient registries, sometimes called patient databases, are a useful tool in any clinical trial patient recruitment strategy. They help researchers identify pot...
Continue reading
Clinical trials play a critical role in developing new treatments and therapies for Parkinson's disease, an age-related degenerative brain condition that causes...
Continue reading
This webinar, hosted by Sano Genetics Partnership Lead Lindsey Wahlstrom-Edwards and featuring representatives from COUCH Health, Lupus Research Alliance, and A...
Continue reading
Choosing a CRO partner affects every phase of a clinical trial. A mismatch in therapeutic expertise, regulatory experience, or service scope can introduce delay...
Continue reading
In this episode of "The Genetics Podcast," host Patrick Short interviews Daniel McArthur, Director of the Centre for Population Genomics at the Garvan Institute...
Continue reading